CVS - CVS Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 7/9/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
82.53B77.43B96.73B82.05B70.79B
Enterprise Value 3
162.14B158.37B178.88B165.45B158.02B
Trailing P/E
11.4411.6822.1817.77N/A
Forward P/E 1
8.908.3110.398.708.10
PEG Ratio (5 yr expected) 1
1.101.002.171.291.20
Price/Sales (ttm)
0.320.300.380.330.29
Price/Book (mrq)
1.271.211.541.341.19
Enterprise Value/Revenue 3
0.622.382.642.562.49
Enterprise Value/EBITDA 6
9.4434.4442.9641.6535.63

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 39.07%
S&P500 52-Week Change 35.66%
52 Week High 377.03
52 Week Low 352.04
50-Day Moving Average 365.11
200-Day Moving Average 365.06

Share Statistics

Avg Vol (3 month) 37.88M
Avg Vol (10 day) 37.48M
Shares Outstanding 51.31B
Float 1.3B
% Held by Insiders 10.19%
% Held by Institutions 179.64%
Shares Short (Jun 14, 2020) 419.8M
Short Ratio (Jun 14, 2020) 42.73
Short % of Float (Jun 14, 2020) 41.52%
Short % of Shares Outstanding (Jun 14, 2020) 41.52%
Shares Short (prior month May 14, 2020) 418.18M

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 43.26%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 33.26%
5 Year Average Dividend Yield 42.53
Payout Ratio 436.23%
Dividend Date 3May 03, 2020
Ex-Dividend Date 4Jul 21, 2020
Last Split Factor 22:1
Last Split Date 3Jun 06, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 2.77%
Operating Margin (ttm)4.77%

Management Effectiveness

Return on Assets (ttm)3.46%
Return on Equity (ttm)11.50%

Income Statement

Revenue (ttm)260.96B
Revenue Per Share (ttm)200.28
Quarterly Revenue Growth (yoy)8.50%
Gross Profit (ttm)44.52B
EBITDA 16.81B
Net Income Avi to Common (ttm)7.22B
Diluted EPS (ttm)5.52
Quarterly Earnings Growth (yoy)41.20%

Balance Sheet

Total Cash (mrq)12.71B
Total Cash Per Share (mrq)9.73
Total Debt (mrq)92.32B
Total Debt/Equity (mrq)141.00
Current Ratio (mrq)0.99
Book Value Per Share (mrq)49.92

Cash Flow Statement

Operating Cash Flow (ttm)14.2B
Levered Free Cash Flow (ttm)11.29B